Fri, January 6, 2023

Drew Ranieri Maintained (AVNS) at Sell with Increased Target to $26 on, Jan 6th, 2023

Drew Ranieri of Morgan Stanley, Maintained "Avanos Medical, Inc." (AVNS) at Sell with Increased Target from $24 to $26 on, Jan 6th, 2023.

Drew has made no other calls on AVNS in the last 4 months.



There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, 0 agree with Drew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Drew


  • Matthew Mishan of "Keybanc" Maintained at Buy with Decreased Target to $34 on, Thursday, November 3rd, 2022